FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742436675> ?p ?o ?g. }

• W2742436675 endingPage "e0182632" @default.
• W2742436675 startingPage "e0182632" @default.
• W2742436675 abstract "Background The comparative performance of different drug-eluting stents (DES) among female patients has not been assessed in a randomized manner. Objectives The SPIRIT Women Clinical Evaluation trial compared the durable polymer everolimus-eluting XIENCE stent (DP-EES) with the durable polymer sirolimus-eluting Cypher stent (DP-SES) in women undergoing percutaneous coronary intervention (PCI). Methods A total of 455 female patients with stable CAD were randomly assigned to receive DP-EES (n = 304) or DP-SES (n = 151). The powered angiographic outcome of the trial was in-stent late lumen loss (LLL) at 9 months after the index procedure. Secondary angiographic end points included in-segment LLL, in-stent and in-segment binary restenosis and percent diameter stenosis. The primary clinical outcome was a composite of all-cause death, myocardial infarction (MI) or target vessel revascularization (TVR). Results At 9-month follow-up, in-stent LLL was 0.19±0.38 mm and 0.11±0.37 mm in patients assigned to DP-EES and DP-SES, respectively. The one-sided upper 95% CI of the difference in in-stent LLL between the groups of 0.08 mm was 0.15 and therefore within the pre-specified non-inferiority margin of 0.17 mm (p for non-inferiority = 0.013). However, the test for superiority showed a borderline significant difference in terms of LLL between DP-EES and DP-SES (p for superiority = 0.044). There were no significant differences in binary restenosis (2.0% vs. 0.72%, p = 0.44) and percent diameter stenosis (14.97±12.17 vs. 13.36±10.82, p = 0.19). The rate of definite stent thrombosis at 12 months was lower in patients treated with DP-EES (0% vs. 2.0%, p = 0.036). Conclusions Among women undergoing PCI, DP-EES was associated with a small but probably clinically relevant increase in in-stent LLL at 9 months as compared to DP-SES and with a lower risk of definite stent thrombosis at 12 months. Trial registration ClinicalTrials.gov NCT01182428. https://clinicaltrials.gov/" @default.
• W2742436675 created "2017-08-17" @default.
• W2742436675 creator A5022983534 @default.
• W2742436675 creator A5035600962 @default.
• W2742436675 creator A5038409870 @default.
• W2742436675 creator A5051530432 @default.
• W2742436675 creator A5052177416 @default.
• W2742436675 creator A5053194091 @default.
• W2742436675 creator A5054117154 @default.
• W2742436675 creator A5060670915 @default.
• W2742436675 creator A5067682458 @default.
• W2742436675 creator A5084120284 @default.
• W2742436675 creator A5088557482 @default.
• W2742436675 creator A5091301686 @default.
• W2742436675 date "2017-08-10" @default.
• W2742436675 modified "2023-10-18" @default.
• W2742436675 title "A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study" @default.
• W2742436675 cites W1428162896 @default.
• W2742436675 cites W1571278713 @default.
• W2742436675 cites W1923114812 @default.
• W2742436675 cites W1966723887 @default.
• W2742436675 cites W1967445101 @default.
• W2742436675 cites W1977494470 @default.
• W2742436675 cites W1989556574 @default.
• W2742436675 cites W2006768325 @default.
• W2742436675 cites W2015712245 @default.
• W2742436675 cites W2028401584 @default.
• W2742436675 cites W2040656084 @default.
• W2742436675 cites W2042031779 @default.
• W2742436675 cites W2046209971 @default.
• W2742436675 cites W2064409947 @default.
• W2742436675 cites W2083435165 @default.
• W2742436675 cites W2083630382 @default.
• W2742436675 cites W2085537260 @default.
• W2742436675 cites W2087217447 @default.
• W2742436675 cites W2102168836 @default.
• W2742436675 cites W2107129548 @default.
• W2742436675 cites W2116657535 @default.
• W2742436675 cites W2118462279 @default.
• W2742436675 cites W2139804268 @default.
• W2742436675 cites W2161895979 @default.
• W2742436675 cites W2166967848 @default.
• W2742436675 cites W2334038053 @default.
• W2742436675 cites W2340643906 @default.
• W2742436675 cites W2340891565 @default.
• W2742436675 cites W2589869295 @default.
• W2742436675 cites W25937319 @default.
• W2742436675 cites W2737117686 @default.
• W2742436675 cites W4230873417 @default.
• W2742436675 cites W4300813589 @default.
• W2742436675 cites W584804003 @default.
• W2742436675 doi "https://doi.org/10.1371/journal.pone.0182632" @default.
• W2742436675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5552121" @default.
• W2742436675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28796809" @default.
• W2742436675 hasPublicationYear "2017" @default.
• W2742436675 type Work @default.
• W2742436675 sameAs 2742436675 @default.
• W2742436675 citedByCount "4" @default.
• W2742436675 countsByYear W27424366752018 @default.
• W2742436675 countsByYear W27424366752020 @default.
• W2742436675 countsByYear W27424366752021 @default.
• W2742436675 countsByYear W27424366752022 @default.
• W2742436675 crossrefType "journal-article" @default.
• W2742436675 hasAuthorship W2742436675A5022983534 @default.
• W2742436675 hasAuthorship W2742436675A5035600962 @default.
• W2742436675 hasAuthorship W2742436675A5038409870 @default.
• W2742436675 hasAuthorship W2742436675A5051530432 @default.
• W2742436675 hasAuthorship W2742436675A5052177416 @default.
• W2742436675 hasAuthorship W2742436675A5053194091 @default.
• W2742436675 hasAuthorship W2742436675A5054117154 @default.
• W2742436675 hasAuthorship W2742436675A5060670915 @default.
• W2742436675 hasAuthorship W2742436675A5067682458 @default.
• W2742436675 hasAuthorship W2742436675A5084120284 @default.
• W2742436675 hasAuthorship W2742436675A5088557482 @default.
• W2742436675 hasAuthorship W2742436675A5091301686 @default.
• W2742436675 hasBestOaLocation W27424366751 @default.
• W2742436675 hasConcept C126322002 @default.
• W2742436675 hasConcept C141071460 @default.
• W2742436675 hasConcept C164705383 @default.
• W2742436675 hasConcept C2777546689 @default.
• W2742436675 hasConcept C2777921159 @default.
• W2742436675 hasConcept C2778213512 @default.
• W2742436675 hasConcept C2778283817 @default.
• W2742436675 hasConcept C2778583881 @default.
• W2742436675 hasConcept C2779699572 @default.
• W2742436675 hasConcept C2780007028 @default.
• W2742436675 hasConcept C2780400711 @default.
• W2742436675 hasConcept C500558357 @default.
• W2742436675 hasConcept C71924100 @default.
• W2742436675 hasConceptScore W2742436675C126322002 @default.
• W2742436675 hasConceptScore W2742436675C141071460 @default.
• W2742436675 hasConceptScore W2742436675C164705383 @default.
• W2742436675 hasConceptScore W2742436675C2777546689 @default.
• W2742436675 hasConceptScore W2742436675C2777921159 @default.
• W2742436675 hasConceptScore W2742436675C2778213512 @default.
• W2742436675 hasConceptScore W2742436675C2778283817 @default.
• W2742436675 hasConceptScore W2742436675C2778583881 @default.
• W2742436675 hasConceptScore W2742436675C2779699572 @default.

• next